Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
Price:
8.34
CNY
-1.88%
Market Closed
Market Cap:
¥3.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
|
CN |
|
C
|
Citra Nusa Holdings Bhd
KLSE:CNH
|
MY |
|
Hotel Holiday Garden
TWSE:2702
|
TW |
|
Digilife Technologies Ltd
SGX:BAI
|
SG |
|
S
|
Seneca Foods Corp
NASDAQ:SENEB
|
US |
|
Discovery Minerals Ltd
OTC:DSCR
|
US |
|
Biotricity Inc
NASDAQ:BTCY
|
CA |
|
Kitazawa Sangyo Co Ltd
TSE:9930
|
JP |
|
C
|
Centrus Energy Corp
AMEX:LEU
|
US |
|
INmune Bio Inc
NASDAQ:INMB
|
US |
|
S
|
Shaftesbury Capital PLC
JSE:SHC
|
UK |
|
Shenzhen Qingyi Photomask Ltd
SSE:688138
|
CN |
|
C
|
Copartner Technology Corp
TWSE:3550
|
TW |
|
W
|
Wonderfi Technologies Inc
OTC:WONDF
|
CA |
|
ADVA Optical Networking SE
XETRA:ADV
|
DE |
|
J
|
JoulWatt Technology Co Ltd
SSE:688141
|
CN |
|
China Zhonghua Geotechnical Engineering Group Co Ltd
SZSE:002542
|
CN |
Multiples-Based Value
The Multiples-Based Value of one
Shenzhen Bioeasy Biotechnology Co Ltd
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 8.34 CNY,
Shenzhen Bioeasy Biotechnology Co Ltd
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Shenzhen Bioeasy Biotechnology Co Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Shenzhen Bioeasy Biotechnology Co Ltd Competitors
Shenzhen Bioeasy Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Shenzhen Bioeasy Biotechnology Co Ltd
SZSE:300942
|
3.3B CNY | 13.3 | 107.1 | 101.4 | 101.4 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.2T JPY | 10.1 | 36.8 | 26.6 | 32 | |
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
55.5B USD | 0 | 0 | 0 | 0 | |
| CH |
|
Alcon AG
SIX:ALC
|
29.2B CHF | 3.6 | 38.2 | 14.7 | 28.6 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
98.2B DKK | 3.5 | 24.5 | 12.9 | 15.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.7B USD | 3 | 29.3 | 12.5 | 17.2 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.4B GBP | 2.4 | 33.4 | 11.7 | 18.2 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.6B USD | 1.1 | -15.4 | 16.7 | 54.2 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
890.2B JPY | 6.9 | 50.3 | 23.8 | 32.4 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
38.2B CNY | 8.4 | 23.1 | 20.8 | 20.8 | |
| CN |
|
Intco Medical Technology Co Ltd
SZSE:300677
|
35.8B CNY | 3.6 | 21 | 31 | 31 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
